Medicines In The Environment: EU Moots Action On ‘Green’ Manufacturing, Pack Sizes, Discharges

Stakeholders in the EU are being asked to give their views on ways of addressing the problem of pharmaceuticals posing public health risks when they enter the environment via their manufacture, use and disposal. “Green” manufacturing and design, closer monitoring of discharges and more appropriate pack sizes are among proposals put forward.

Ecology
The EU is looking into the effects of pharmaceuticals on the environment

More from Compliance

More from Pink Sheet